About Index Trending news
Analyze
Pricing
Dicerna Pharma

Dicerna Pharma

Work at Dicerna Pharma? Add yourself to this profile

Dicerna Pharma

Dicerna Pharmaceuticals is focused on the discovery and development ofinnovative treatments for rare inherited diseases.
Edit Profile
More info

Elsewhere

Companies in the same industry

Veracyte, Inc. Veracyte, Inc. REACH Health REACH Health NuscriptRX NuscriptRX TriVascular TriVascular Aratana Therapeutics Aratana Therapeutics Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical Adnexus Adnexus SutroVax SutroVax Empire Genomics Empire Genomics Impedans Impedans

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
Add round
30 Mar 2017
$70,000,000
Post-IPO equity
RA Capital Management, Skyline Ventures, Domain Associates, +3

Dicerna scores $70 mln

PE Hub
31 Jul 2013
$60,000,000
Venture capital (Series C)
RA Capital Management, SR One, Skyline Ventures, +6
21 Oct 2010
$4,000,000
Venture capital (Series B)
SR One, HealthCare Ventures
04 Jan 2010
$124,000,000
Venture capital
Kyowa Hakko Kirin